Microbot Medical Inc.

Microbot is a medical device company focused on the research, design, and development of next-generation robotic endoluminal surgery devices for minimally invasive surgery. The company leverages its robotic technologies to improve surgical outcomes for patients. Using its LIBERTY® technological platform, Microbot has developed the first fully disposable robot for various endovascular interventional procedures. The LIBERTY® Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices, such as microcatheters, within the body's vasculature. It is intended for the remote delivery and manipulation of guidewires and catheters, and remote manipulation of guide catheters to facilitate navigation to anatomical targets. The current focus for this system is the peripheral vasculature market. This system is designed to eliminate the need for extensive capital equipment, dedicated Cath-lab rooms, and dedicated staff. The FDA-cleared LIBERTY® Endovascular Robotic Surgical System features a compact, single-use design that can be operated remotely, aiming to reduce radiation exposure and physical strain on physicians, and potentially eliminate the use of consumables. The addressable market for the current version of the LIBERTY® Endovascular Robotic Surgical System includes the peripheral interventional radiology market.